ACCIPITER CAPITAL MANAGEMENT, LLC
Follow13F filer, CIK 1280190, Jersey City, NJ
ACCIPITER CAPITAL MANAGEMENT, LLC reported $47,898,000 across 3 holdings for the quarter ended 2017-06-30, in a 13F-HR filed 2017-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000921895-17-002150
- Period
- 2017-06-30
- Reported value
- $47.9M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TEVAadded | +2,145 | $71.3K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q2 2017
Share positions as resolved from 13F-HR 0000921895-17-002150, largest first. % of portfolio is the value over $47,898,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| FORESIGHT ENERGY LPFORESIGHT ENERGY LP | 7,622,302 | $37.1M | 77.5% | 0 | |||
| TEVATEVA PHARMACEUTICAL INDS LTD | 202,145 | $6.71M | 14.02% | +2,145 | Timeline | ||
| SHIRE PLCSHIRE PLC | 24,578 | $4.06M | 8.48% | 0 |
How Q2 2017 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000921895-17-002150 | base | 2017-08-14 | acceptance time not in the bulk data set |